http://www.jmdutton.com/ Latest research alerts from Dutton Associates. en-us Wed, 20 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/DYIHY/index.html?08202008 Wed, 20 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/ELC/index.html?08202008 Wed, 20 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/PTSC/index.html?08202008 Tue, 19 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/CPEU/index.html?08192008 Tue, 19 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/PTSC/index.html?08192008 Mon, 18 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/NEXM/index.html?08182008 Mon, 18 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/ELC/index.html?08182008 Mon, 18 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/MBKR/index.html?08182008 Mon, 18 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/PEDH/index.html?08182008 Fri, 15 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/IMRX/index.html?08152008 Fri, 15 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/JADE/index.html?08152008 Fri, 15 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/EHHA/index.html?08152008 Fri, 15 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/PBIO/index.html?08152008
The Company posted a net loss for the quarter ended of $1.57 million or $0.72 per share, basic and diluted, compared to a profit of $0.16 million or $0.01 per share from continuing operations for the same quarter in 2007. Pressure BioSciences, Inc. (Nasdaq: PBIO) announced on August 14, 2008 financial results for the quarter ended June 30, 2008. The Company continues to invest strongly in the development and commercialization of its novel platform, Pressure Cycling Technology (PCT). In June 2008, Pressure BioSciences engaged Emerging Growth Equities, Ltd. ("EGE"), an investment banking firm located in King of Prussia, PA, to assist in raising equity financing to support its research and development activities, commercialization efforts, working capital requirements, and general corporate purposes. As of June 30, 2008, the Company had cash and cash equivalents of $2.84 million compared with $5.42 million as of December 31, 2007.

In June 2008, Pressure BioSciences engaged Emerging Growth Equities, Ltd. ("EGE"), an investment banking firm located in King of Prussia, PA, to assist in raising equity financing to support its research and development activities, commercialization efforts, working capital requirements, and general corporate purposes. While we are concerned about the Company's current financial situation, we are heartened that it has dramatically reduced expenses, mainly by the reduction of its sales force, as well as the engagement of an investment banking firm to help provide equity financing. We are also heartened to learn that the Company has, to date, installed nine Barocycler instruments in third quarter, and expects at least an additional five installations prior to the end of third quarter. In light of potential dilution from the Company's current financing plans to raise $8 million, we are adjusting our 12-month price target from $8.00 to $7.00. This target remains more than 100% above current share price, and we are maintaining our Strong Speculative Buy rating for the shares.]]> Fri, 15 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/SOYO/index.html?08152008 Thu, 14 Aug 2008 07:00:00 GMT http://www.jmdutton.com/research/MRY/index.html?08142008